Literature DB >> 8523366

Radiographic progression in rheumatoid arthritis: results of 3 comparative trials.

P L van Riel1, D M van der Heijde, I H Nuver-Zwart, L B van de Putte.   

Abstract

In 3 clinical trials the effects of 6 different disease modifying antirheumatic drugs on radiographic progression were evaluated. Despite the wide range in disease duration of patients in the different studies, a statistically significant slowing of radiographic progression was found in those patients treated with aurothioglucose, sulfasalazine, and methotrexate compared to auranofin, hydroxychloroquine, and azathioprine, respectively. These drugs might therefore be considered as disease controlling antirheumatic drugs.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8523366

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  6 in total

Review 1.  Matrix metalloproteinase inhibitors in rheumatic diseases.

Authors:  D R Close
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands.

Authors:  C H van Jaarsveld; J W Jacobs; M J van der Veen; A A Blaauw; A A Kruize; D M Hofman; H L Brus; G A van Albada-Kuipers; A H Heurkens; E J ter Borg; H C Haanen; C van Booma-Frankfort; Y Schenk; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

Review 3.  Remission, a therapeutic goal in inflammatory arthropathies? Clinical data from adalimumab studies.

Authors:  Carlomaurizio Montecucco
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  Radiography of rheumatoid arthritis in the time of increasing drug effectiveness.

Authors:  F Wolfe; V Strand
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.592

5.  Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.

Authors:  A H Gerards; R B M Landewé; A P A Prins; G A W Bruyn; H S Goei Thé; R F J M Laan; B A C Dijkmans; G A W Bruijn
Journal:  Ann Rheum Dis       Date:  2003-04       Impact factor: 19.103

Review 6.  Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

Authors:  Klaus P Machold; Valerie P K Nell; Tanja A Stamm; Josef S Smolen
Journal:  Arthritis Res Ther       Date:  2006-05-15       Impact factor: 5.156
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.